Novartis – Recall of Sandimmune® (cyclosporine) and Neoral® (cyclosporine)
March 18, 2020 - Novartis announced a recall of some lots of Sandimmune (cyclosporine) and Neoral (cyclosporine) 100 mg soft gelatin capsule prescription drug blister packages because the drug packaging is not child resistant as required by the Poison Prevention Packaging Act, posing a risk of poisoning if the contents are swallowed by young children.
Top